Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 41 of 41 entries
View as:

Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00351221 Org: User:
Start: - End: - Due: -

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Phase: N/A Priority: Normal
NCT ID: NCT01315691 Org: User:
Start: - End: - Due: -

A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT04594369 Org: User:
Start: 12/01/20 End: 10/28/24 Due: 10/28/25

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

Phase: N/A Priority: Normal
NCT ID: NCT04677543 Org: User:
Start: 12/22/20 End: 05/09/23 Due: 05/09/24

A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT05176951 Org: User:
Start: 12/22/22 End: 03/14/24 Due: 03/14/25

A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05826574 Org: User:
Start: 05/10/23 End: 07/16/23 Due: 07/16/24

A Study of the Absorption, Metabolism, and Excretion of [14C]-Brensocatib Following a Single Oral Administration in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05652257 Org: User:
Start: 08/13/21 End: 09/14/21 Due: 09/14/22

Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212

Phase: N/A Priority: Normal
NCT ID: NCT02628600 Org: User:
Start: 02/05/16 End: 10/17/18 Due: 10/17/19

Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa

Phase: N/A Priority: Normal
NCT ID: NCT06238856 Org: User:
Start: 05/12/04 End: 02/08/05 Due: 02/08/06

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants

Phase: N/A Priority: Normal
NCT ID: NCT05927597 Org: User:
Start: 01/09/19 End: 08/01/19 Due: 08/01/20

Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung

Phase: N/A Priority: Normal
NCT ID: NCT00102531 Org: User:
Start: 01/12/05 End: 03/17/08 Due: 03/17/09

A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05999942 Org: User:
Start: 06/02/04 End: 06/29/04 Due: 06/29/05

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT05147805 Org: User:
Start: 08/24/22 End: 03/27/25 Due: 03/27/26

A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06344728 Org: User:
Start: 04/30/24 End: 05/24/24 Due: 05/24/25

Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria

Phase: N/A Priority: Normal
NCT ID: NCT01315236 Org: User:
Start: 04/19/12 End: 06/18/15 Due: 06/18/16

Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)

Phase: N/A Priority: Normal
NCT ID: NCT00777296 Org: User:
Start: 02/22/07 End: 02/27/08 Due: 02/27/09